Back to search
FDAFDA · Food and drugs·Recall number Z-1362-2020

CareFusion Alaris PCA Module, Model 8120

Published March 11, 2020 · Recall initiated: February 4, 2020

Summary

FDA records medical device Class I recall Z-1362-2020, published March 11, 2020 and initiated February 4, 2020. Recalling firm: CareFusion 303, Inc.; Status: Ongoing; Reported quantity: 83015; Lot: Software versions 12.1.0, and 9.33 and prior. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

1)Error 255-XX-XXX results in inability to edit settings 2)Delay options programming may result in no KVO rate/therapy interruption 3)Software errors results in no low battery alarm/infusion stopping 4)Medium priority KVO/End of Infusion alarms may result in unrecognized infusion completion 5)Custom concentration data entry errors results in concentrations being lower/higher than medication orders

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
CareFusion 303, Inc.
Distributor
Worldwide Distribution: (U.S. Nationwide) to states of: CO, SC, NY, CA, LA, TX, AK, ID, VA, DE, FL, PA, KY, KS, TN, WA, MS, IL, GA, AR, NC, NV, NE, OR, RI, WI, HI, GU, PR, MA, IA, CT, MI, AZ, ME, MT, IN, OH, WV, WY, MN, AL, NH, OK, DC, NJ, MO, SD, UT, NM, MD, VT, MP, ND, AS; and countries of: Canada, Australia, New Zealand, the Middle East, South Africa, Taiwan, Southeast Asia and the European Union.
Lot
Software versions 12.1.0, and 9.33 and prior
Risk classification
Class I
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was CareFusion Alaris PCA Module, Model 8120 recalled?

Yes. FDA published recall Z-1362-2020 on March 11, 2020. Reported hazard: 1)Error 255-XX-XXX results in inability to edit settings 2)Delay options programming may result in no KVO rate/therapy interruption 3)Software errors results in no low battery alarm/infusion stopping 4)Medium priority KVO/End of Infusion alarms may result in unrecognized infusion completion 5)Custom concentration data entry errors results in concentrations being lower/higher than medication orders

What should I do if I have this product?

Voluntary: Firm initiated · Letter